- Home
- BNTX vs WSM Comparison
BNTX vs WSM Comparison
Compare BNTX & WSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | WSM |
|---|---|---|
| Founded | 2008 | 1956 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 20.8B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNTX | WSM |
|---|---|---|
| Price | $96.21 | $178.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $137.40 | ★ $200.07 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 11-03-2025 | 11-19-2025 |
| Dividend Yield | N/A | ★ 1.49% |
| EPS Growth | N/A | ★ 10.21 |
| EPS | N/A | ★ 9.11 |
| Revenue | $3,698,814,972.00 | ★ $7,911,905,000.00 |
| Revenue This Year | N/A | $2.64 |
| Revenue Next Year | $9.49 | $3.22 |
| P/E Ratio | ★ N/A | $19.45 |
| Revenue Growth | 3.70 | ★ 5.10 |
| 52 Week Low | $81.20 | $130.07 |
| 52 Week High | $129.27 | $219.98 |
Technical Indicators
Market Signals| Indicator | BNTX | WSM |
|---|---|---|
| Relative Strength Index (RSI) | 38.91 | 42.61 |
| Support Level | $94.00 | $170.13 |
| Resistance Level | $104.05 | $184.72 |
| Average True Range (ATR) | 3.41 | 6.95 |
| MACD | -0.46 | -0.01 |
| Stochastic Oscillator | 11.26 | 33.87 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About WSM Williams-Sonoma Inc. (DE)
With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. Namesake Williams-Sonoma (154 stores) offers high-end cooking essentials, while Pottery Barn (181) provides casual home accessories. West Elm (119) is an emerging concept for young professionals, and Rejuvenation (11) offers lighting and house parts. Brand extensions include Pottery Barn Kids and Pottery Barn Teen (44) as well as Mark & Graham and GreenRow. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.